AstraZeneca PLC Non-GAAP EPS of $2.79, revenue of $16.21B beats by $210M; reaffirms FY2026 outlook

Nigeria South Africa Ghana Senegal Uganda Kenya Morocco Egypt Zimbabwe Tanzania Algeria Ethiopia Sudan Ivory Coast Libya Somalia Tunisia Zambia Mozambique DR Congo Angola

India Malaysia Iran Japan China South Korea Israel Pakistan Indonesia Philippines United Arab Emirates Saudi Arabia Turkey Cambodia Singapore Thailand Bangladesh Vietnam North Korea Yemen Palestine Nepal Taiwan Kazakhstan Iraq Syria Lebanon Qatar Afghanistan Sri Lanka Jordan Kuwait Uzbekistan Laos

United Kingdom Russia Germany France Spain Italy Ukraine Portugal Ireland Poland Netherlands Austria Finland Greece Romania Switzerland Belgium Czech Republic Hungary Denmark Sweden Norway Serbia Croatia Georgia Bulgaria Belarus Slovakia Slovenia Iceland

United States Mexico Canada Dominican Republic Costa Rica Guatemala Puerto Rico Honduras Jamaica Cuba Panama Belize Nicaragua El Salvador Haiti Bahamas Trinidad and Tobago Barbados

Brazil Peru Colombia Ecuador Argentina Venezuela Bolivia Uruguay Chile Paraguay

Australia New Zealand Papua New Guinea Fiji